If you are one of the psoriasis patients out there, chances are that you are keen at following recent news about psoriasis happenings and treatments in order to stay updated. Thanks to social media advancement in recent times, doing this is much easier than ever before. Google Alerts is one of the best tools to use for this purpose that will send you many blogs and news articles about psoriasis and other related search terms. You can also easily find new information and articles being posted on the Internet through Twitter.<\/p>\n
More often than not, most of this news is majorly about new psoriasis treatments being developed. Many medical websites, financial services sites and news organizations like Reuters are always at the forefront in broadcasting the latest happenings in the world of psoriasis. One of the new items talked about this week was mainly focused about a biopharmaceutical company that had introduced a new psoriasis drug. Celgene Company hit headlines with their new drug called apremilast which was of course good news to people suffering with this condition.<\/p>\n
There is yet another source that you could be interested in where psoriasis medications being developed are listed. This is NPF- National Psoriasis Foundation, which is very resourceful when it comes to this. Just visit their web page named Drugs in Development. By linking to the page, you will realize that the first medication listed under the \u2018Oral treatments in pipeline\u2019 is premilast by Celgene. The website says that questions about the safety and effectiveness of the drug when used by big groups of people are answered at Phase III. This report has very solid results and it is highly expected that the drug is going to pass regulatory approval by the time the year comes to an end.<\/p>\n